The invention relates to a medical chewing gum comprising gum base polymers and an active pharmaceutical ingredient the gum base polymers comprising polyvinyl acetate and vinyl laurate vinyl acetate copolymer in an amount of more than 90% by weight wherein the gum base polymers include 20 95% by weight of polyvinyl acetate and 80% by weight of vinyl laurate vinyl acetate copolymer and wherein the chewing gum contains no polyterpene resins and no resins based on gum rosin wood rosin or tall oil resin.
